S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Laser breakthrough could send stock soaring 2,467% (Ad)
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Laser breakthrough could send stock soaring 2,467% (Ad)
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Laser breakthrough could send stock soaring 2,467% (Ad)
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Laser breakthrough could send stock soaring 2,467% (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Laser breakthrough could send stock soaring 2,467% (Ad)
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
NASDAQ:GRAY

Graybug Vision (GRAY) Stock Forecast, Price & News

$2.66
-0.07 (-2.56%)
(As of 09/29/2023 ET)
Compare
Today's Range
$2.54
▼
$2.70
50-Day Range
$2.64
▼
$5.50
52-Week Range
$5.00
▼
$22.12
Volume
1,319 shs
Average Volume
2,165 shs
Market Capitalization
$4.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

GRAY stock logo

About Graybug Vision (NASDAQ:GRAY) Stock

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

GRAY Price History

GRAY Stock News Headlines

August 3, 2023 | markets.businessinsider.com
Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer
June 10, 2023 | appleinsider.com
Apple Vision Pro $3,499 mixed-reality headset launches at WWDC after years of rumors
October 1, 2023 | Legacy Research (Ad)
Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
March 28, 2023 | marketwatch.com
Ocular Drug Delivery Technology Market Outlook By 2031
March 22, 2023 | finanznachrichten.de
Graybug Vision, Inc. Announces Name and Trading Symbol Change
March 21, 2023 | finanznachrichten.de
Graybug Vision, Inc.: Graybug Announces Name and Trading Symbol Change
March 21, 2023 | benzinga.com
Graybug Vision Stock (NASDAQ:GRAY), Dividends
March 20, 2023 | finance.yahoo.com
CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
October 1, 2023 | Stansberry Research (Ad)
Bank Collapse Causes Gold Prices to Soar
Silicon Valley Bank was the second-largest bank in American history to fail, and investors have started piling into the safety and security of gold. But if you're not taking advantage of a little-known way to invest for around $5 today, you're missing out.
March 20, 2023 | finance.yahoo.com
Individual investors are Graybug Vision, Inc.'s (NASDAQ:GRAY) biggest owners and were hit after market cap dropped US$31m
March 20, 2023 | finance.yahoo.com
Graybug Announces Name and Trading Symbol Change
February 27, 2023 | marketwatch.com
Ocular Drug Delivery Technology Market is Booming Worldwide with Top Countries Data
February 14, 2023 | businesswire.com
GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY
February 9, 2023 | finanznachrichten.de
DelveInsight Business Research, LLP: The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
February 9, 2023 | yahoo.com
The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
January 25, 2023 | seekingalpha.com
GRAY Graybug Vision, Inc.
December 6, 2022 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL
December 5, 2022 | wsj.com
INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of Graybug Vision, Inc. - GRAY
November 24, 2022 | benzinga.com
GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY
November 22, 2022 | marketwatch.com
GRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to Shareholders
November 22, 2022 | marketwatch.com
Graybug Vision Shares Fall Premarket on CalciMedica Tie-Up >GRAY
November 22, 2022 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedica
November 22, 2022 | finance.yahoo.com
Graybug Vision Agrees To Merge With Inflammatory Disease-Focused Biopharma
November 22, 2022 | finanznachrichten.de
Graybug Vision, Inc.; CalciMedica Inc.: Graybug and CalciMedica Enter into Definitive Merger Agreement
November 10, 2022 | finance.yahoo.com
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
September 16, 2022 | finance.yahoo.com
Diality Names Pamela Wapnick as Chief Financial Officer
August 11, 2022 | msn.com
Graybug Vision: Q2 Earnings Insights
See More Headlines
Receive GRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter.

GRAY Company Calendar

Last Earnings
11/11/2021
Today
10/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GRAY
CUSIP
N/A
CIK
1534133
Web
www.graybug.com
Phone
N/A
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($24.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-35,600,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-77.61%
Return on Assets
-71.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.73
Quick Ratio
10.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
1.59

Miscellaneous

Outstanding Shares
1,571,000
Free Float
20,250,000
Market Cap
$4.18 million
Optionable
Not Optionable
Beta
1.20
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Frederic Guerard Pharm.D. (Age 49)
    Pres, CEO, Sec. & Director
    Comp: $931.02k
  • Mr. Robert S. BreuilMr. Robert S. Breuil (Age 60)
    CFO & Treasurer
    Comp: $577.47k
  • Dr. Gerald D. Cagle Ph.D. (Age 78)
    Sr. Advisor & Head of Bus. Devel.
    Comp: $44.67k
  • Dr. Parisa Zamiri M.D. (Age 57)
    Ph.D., Chief Medical Officer
    Comp: $662.11k
  • Dr. Peter A. Campochiaro M.D.
    Co-Founder
  • Dr. Peter J. McDonnell M.D. (Age 63)
    Co-Founder
  • Ms. Bettina Maunz
    Chief People Officer & Head of Communications
  • Mr. Ming Yang
    Sr. VP of R&D
  • Dr. Ward M. Peterson Ph.D.
    Sr. VP of Preclinical Devel.
  • Mr. Ali Kakavand Ph.D.
    VP & Head of Program Management

Key Competitors

View All Competitors













GRAY Stock - Frequently Asked Questions

How have GRAY shares performed in 2023?

Graybug Vision's stock was trading at $7.00 on January 1st, 2023. Since then, GRAY stock has decreased by 62.0% and is now trading at $2.6595.
View the best growth stocks for 2023 here.

How were Graybug Vision's earnings last quarter?

Graybug Vision, Inc. (NASDAQ:GRAY) issued its quarterly earnings data on Thursday, November, 11th. The company reported ($5.32) earnings per share for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14.

When did Graybug Vision's stock split?

Shares of Graybug Vision reverse split on the morning of Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Graybug Vision IPO?

(GRAY) raised $75 million in an initial public offering on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler acted as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers.

What is Graybug Vision's stock symbol?

Graybug Vision trades on the NASDAQ under the ticker symbol "GRAY."

How do I buy shares of Graybug Vision?

Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Graybug Vision's stock price today?

One share of GRAY stock can currently be purchased for approximately $2.66.

How much money does Graybug Vision make?

Graybug Vision (NASDAQ:GRAY) has a market capitalization of $4.18 million. The company earns $-35,600,000.00 in net income (profit) each year or ($24.23) on an earnings per share basis.

How can I contact Graybug Vision?

The official website for the company is www.graybug.com. The company can be reached via email at ir@graybug.vision.

This page (NASDAQ:GRAY) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -